BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:44 PM
Jan 05, 2009
 |  BC Extra  |  Company News

UCB receives complete response for Cimzia

UCB (Euronext:UCB) said it received a complete response letter from FDA for a BLA for Cimzia certolizumab to treat adult patients with active rheumatoid arthritis. UCB...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >